Physician profile
Thomas Mclellan
NPI 1316445760
$1,566.81
in general payments reported to CMS, 2019-2025
14 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10.69 · 2022: $306 · 2023: $766 · 2024: $213 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $486.41 | 2023-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $234.30 | 2022-2023 | Trelegy Ellipta, Nucala, Shingrix |
| Regeneron Healthcare Solutions, INC. | $195.98 | 2022-2023 | Dupixent |
| Genzyme Corporation | $159.66 | 2022-2024 | |
| Baxter Healthcare | $126.76 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Starling System, Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $112.52 | 2022-2023 | Recarbrio, Zerbaxa |
| Mylan Specialty L.P. | $58.50 | 2022-2023 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $40.52 | 2023 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.06 | 2021-2025 | Lifevest |
| Melinta Therapeutics, LLC | $30.65 | 2022-2023 | Rezzayo, Kimyrsa, Vabomere |
| Teva Pharmaceuticals USA, INC. | $25.56 | 2022 | |
| Amgen INC. | $22.73 | 2023-2024 | Tezspire |
| Insmed, INC. | $21.73 | 2025 | Arikayce |
| Phadia US INC. | $18.43 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.